Recent Finacing
Recent Raise
NUCLIDIUM is a radiopharmaceutical company developing copper-based radiotheranostics that combine diagnostic imaging and targeted therapeutic isotopes.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at NUCLIDIUM.
